Page last updated: 2024-11-08

2-chloro-4-methylpentanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-chloroisocaproic acid: branched-chain alpha-ketoacid dehydrogenase kinase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID169071
SCHEMBL ID936160
MeSH IDM0111206

Synonyms (22)

Synonym
LS-13161
2-chloroisocaproic acid
cbqbiprpihikpw-uhfffaoysa-
inchi=1/c6h11clo2/c1-4(2)3-5(7)6(8)9/h4-5h,3h2,1-2h3,(h,8,9)
29671-29-2
pentanoic acid, 2-chloro-4-methyl-
2-chloro-4-methylpentanoic acid
2-chloro-4-methylpentanoate
2-chloro-4-methylvalerate
alpha-chloroisocaproate
2-cica
FT-0638794
AKOS022504716
CBQBIPRPIHIKPW-UHFFFAOYSA-N
SCHEMBL936160
(2r)-2-chloro-4-methylpentanoic acid
E72665
2-chloro-4-methylpentanoicacid
DTXSID20952133
SB44861
EN300-150956
PD194182
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (82.35)18.7374
1990's2 (11.76)18.2507
2000's1 (5.88)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.15 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.04 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]